
Alpha Profiles · Company Profile
Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United…
https://registry.alpha.ac/companies/arcturus-therapeutics-holdings-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: ARCT
- Verification
- Partially verified
- Last reviewed
- 2026-09-17T04:46:22.304263+00:00
Overview
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-17T04:46:22.304263+00:00
